A study published in the New England Journal of Medicine showed that maintenance theraphy with rituximab for older mantle cell patients almost
Rituximab Best for Elderly Mantle Cell Lymphoma Patients
A study published in the New England Journal of Medicine showed that maintenance theraphy with rituximab for older mantle cell patients almost doubled the duration of remission of those who had a response to induction theraphy and improved the overall survivoral amoung patients who had a response to R-CHOP.
